C. Alandag Et Al. , "Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer," ANTI-CANCER DRUGS , vol.33, no.4, pp.389-393, 2022
Alandag, C. Et Al. 2022. Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer. ANTI-CANCER DRUGS , vol.33, no.4 , 389-393.
Alandag, C., Karaman, E., & Yuce, E., (2022). Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer. ANTI-CANCER DRUGS , vol.33, no.4, 389-393.
Alandag, Celal, ELANUR KARAMAN, And Elif Yuce. "Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer," ANTI-CANCER DRUGS , vol.33, no.4, 389-393, 2022
Alandag, Celal Et Al. "Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer." ANTI-CANCER DRUGS , vol.33, no.4, pp.389-393, 2022
Alandag, C. Karaman, E. And Yuce, E. (2022) . "Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer." ANTI-CANCER DRUGS , vol.33, no.4, pp.389-393.
@article{article, author={Celal Alandag Et Al. }, title={Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer}, journal={ANTI-CANCER DRUGS}, year=2022, pages={389-393} }